Back to Companies
Immunovant, Inc.
IMVTNasdaqCIK: 0001764013
Immunovant, Inc. (IMVT) shows 48 recent insider filings from 13 insiders, with 1 buying and 10 selling. With $350.0M in purchases and $14.9M in sales, the recent tape is heavily weighted toward buying (a net purchase of $335.1M). Roivant Sciences Ltd. is the most active by dollar volume, and the single largest transaction was $350.0M by Roivant Sciences Ltd.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$443.7M
Purchases
$350.0M
Sales
$14.9M
Unique Insiders
13
Recent Insider Trades
48 loaded
| Jul 24 | IMVT Immunovant, Inc. | Pande Atul | Director | Sell | $59.7K |
| Jul 24 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $110.5K |
| Jul 24 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Sell | $263.0K |
| Jul 10 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $47.7K |
| Jul 10 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $137.9K |
| Jul 10 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | $80.5K |
| Jul 6 | IMVT Immunovant, Inc. | Venker Eric | Chief Executive Officer, Director | Sell | $119.0K |
| Jun 26 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | $678.6K |
| Jun 26 | IMVT Immunovant, Inc. | Pande Atul | Director | Sell | $57.0K |
| Jun 26 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $682.9K |
| Jun 26 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $1.5M |
| Jun 26 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Sell | $384.6K |
| Jun 22 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $93.2K |
| Jun 16 | IMVT Immunovant, Inc. | Pande Atul | Director | Sell | $51.0K |
| May 29 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Sell | $7.4M |
| May 20 | IMVT Immunovant, Inc. | Pande Atul | Director | Sell | $192.0K |
| May 1 | IMVT Immunovant, Inc. | Susman Robert Graham | Director | Sell | $68.0K |
| Apr 10 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | $216.6K |
| Apr 10 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $128.2K |
| Apr 10 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $251.6K |
| Apr 9 | IMVT Immunovant, Inc. | Torti Frank | Director | Grant | $2.2M |
| Apr 9 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Grant | $1.5M |
| Apr 9 | IMVT Immunovant, Inc. | Susman Robert Graham | Director | Grant | $173.8K |
| Apr 9 | IMVT Immunovant, Inc. | Bauer Jake | Director | Grant | $173.8K |
| Apr 9 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Grant | $3.0M |
| Apr 9 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | $173.8K |
| Apr 9 | IMVT Immunovant, Inc. | Pande Atul | Director | Grant | $173.8K |
| Apr 9 | IMVT Immunovant, Inc. | Hughes Douglas J. | Director | Grant | $173.8K |
| Apr 9 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Grant | $2.3M |
| Apr 3 | IMVT Immunovant, Inc. | Venker Eric | Chief Executive Officer, Director | Sell | $342.9K |
| Mar 20 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $71.8K |
| Feb 27 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | $90.2K |
| Jan 23 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $51.5K |
| Jan 9 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $31.9K |
| Dec 19 | IMVT Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | $290.9K |
| Dec 12 | IMVT Immunovant, Inc. | Roivant Sciences Ltd. | Insider | Buy | $350.0M |
| Dec 3 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Sell | $517.2K |
| Dec 3 | IMVT Immunovant, Inc. | Hughes Douglas J. | Director | Sell | $348.7K |
| Nov 21 | IMVT Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | $298.2K |
| Oct 24 | IMVT Immunovant, Inc. | Geffner Michael | Chief Medical Officer | Sell | $49.4K |
| Oct 24 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $48.0K |
| Oct 10 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $25.8K |
| Oct 10 | IMVT Immunovant, Inc. | Geffner Michael | Chief Medical Officer | Sell | $20.7K |
| Jul 30 | IMVT Immunovant, Inc. | Venker Eric | Chief Executive Officer, Director | Award | $46.3M |
| Jul 25 | IMVT Immunovant, Inc. | Geffner Michael | Chief Medical Officer | Sell | $43.3K |
| Jul 25 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $50.9K |
| Jul 11 | IMVT Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | $26.2K |
| Jul 11 | IMVT Immunovant, Inc. | Geffner Michael | Chief Medical Officer | Sell | $20.0K |
48 filings